SCHEMBL16124487

SCHEMBL16124487

CC(=O)CCc1ccc(I)c(O)c1I

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ IAPP P10997 4/20 0.50
▸ ALDH1A1 P00352 3/20 0.40
▸ LMNA P02545 2/20 0.39
▸ PRKCI P41743 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ TRPV1 Q8NER1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14484747 0.79 CYP4F2 (0.51) ALDH1A1LMNASMN1; SMN2KDM4ECYP1A2
SCHEMBL22991491 0.75 CA2 (0.33) ALDH1A1KDM4ETP53MAPT
SCHEMBL16124476 0.75 PCNA (0.48) IAPPPOLB
SCHEMBL6559326 0.73 TYR (0.50) ALDH1A1LMNAHTTKDM4ETP53
SCHEMBL22991646 0.73 TSHR (0.31) —
SCHEMBL26046412 0.72 IAPP (0.70) IAPPALDH1A1LMNAPRKCI
SCHEMBL17361342 0.72 IAPP (0.55) IAPPALDH1A1LMNASMN1; SMN2HTT
SCHEMBL16124488 0.71 LMNA (0.43) ALDH1A1LMNASMN1; SMN2HTTKDM4E
SCHEMBL28606012 0.69 IAPP (0.61) IAPPALDH1A1LMNAPRKCIMAPT
SCHEMBL7780853 0.68 NPSR1 (0.44) SMN1; SMN2SLC6A3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY MKI67, PCNA, PCLAF IAPP 2513/4885ALDH1A1 2933/4885LMNA 2018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback